Olmesartan medoxomil-induced acute renal failure in a premature newborn following maternal exposure during pregnancy: A case report and review of the literature

  • Krishna Dathan
  • V Lakhshmi
Keywords: Acute renal failure, Oligohydramnios, Olmesartan medoxomil

Abstract

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers (ARBs) are widely used antihypertensive with well-recognized renoprotective and cardioprotective effects. Although treatment with these agents generally does not result in adverse metabolic consequences, their use during human pregnancy has been associated with negative reactions. Here, we report a premature baby with a history of oligohydramnios and maternal exposure to the ARB olmesartan medoxomil who was transferred to our institution with acute renal failure.

Published
2018-03-20
How to Cite
Dathan, K., & Lakhshmi, V. (2018). Olmesartan medoxomil-induced acute renal failure in a premature newborn following maternal exposure during pregnancy: A case report and review of the literature. Indian Journal of Case Reports, 4(2), 105-106. Retrieved from http://atharvapub.net/index.php/IJCR/article/view/812
Section
Case Report